Cranberry Extract
CAS 91770-88-6
Cranberry Extract (CAS 91770-88-6) is a pharmaceutical compound with 0 bioactivity targets and 1,045 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
CRANBERRY EXTRACT is linked to DTXSID701042715 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Cranberry Extract used for in pharmaceutical contexts?
Cranberry Extract (CAS 91770-88-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Cranberry Extract?
Cranberry Extract has 1,045 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal discomfort, Abdominal distension, Abdominal hernia, Abdominal pain, Abdominal pain upper. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Cranberry Extract also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Vaccinium Macrocarpon Fruit Extract with EU status "permitted".
What clinical phase is Cranberry Extract in?
No phase 1-4 clinical development badge is rendered for Cranberry Extract because the matched compound identifier rows do not contain a max-phase value.